• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在全视网膜光凝术中,与传统激光系统相比,帕斯卡激光平台产生的疼痛反应更少:一项随机临床试验。

PASCAL laser platform produces less pain responses compared to conventional laser system during the panretinal photocoagulation: a randomized clinical trial.

作者信息

Inan Sibel, Polat Onur, Yıgıt Safiye, Inan Umit Ubeyt

机构信息

Department of Ophthalmology, Afyon Kocatepe University, Faculty of Medicine, Afyonkarahisar, Turkey.

Ophthalmology Clinic, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey.

出版信息

Afr Health Sci. 2018 Dec;18(4):1010-1017. doi: 10.4314/ahs.v18i4.22.

DOI:10.4314/ahs.v18i4.22
PMID:30766567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6354857/
Abstract

BACKGROUND

Most of patients experience pain during the panretinal photocoagulation(PRP). Laser photocoagulation delivery has advanced with the introduction of pattern-scanning laser systems (PASCAL). Shorter pulse duration and less choroidal penetration believed to reduce pain during the laser treatment.

OBJECTIVES

To compare the severity of expressed pain scores in patients with PDR who underwent PRP either with PASCAL laser or conventional laser.

METHODS

A total of 28 patients with a diagnosis of PDR who were scheduled for bilateral PRP therapy were enrolled into the prospective study. Both eyes were treated within the same session and while one eye was treated with PASCAL the other was treated with conventional laser randomly. Pulse duration was adjusted to 100-ms in conventional laser and 30 ms in PASCAL. The severity of pain was graded using a verbal scale and a visual analog scale (VAS).

RESULTS

Mean age was 61.36±9.10 years. Mean verbal and VAS scores were 1.32±0.47 and 2.86±1.21 in the PASCAL laser and 2.39±0.49 and 5.75±1.35 in the conventional laser group, respectively. Differences between expressed pain scores obtained by both two scales were statistically significant (p<0.001).

CONCLUSION

PASCAL laser significantly alleviates pain levels possibly due to the shorter laser pulse duration and lower intensity.

摘要

背景

大多数患者在进行全视网膜光凝(PRP)时会感到疼痛。随着模式扫描激光系统(PASCAL)的引入,激光光凝技术有了进步。较短的脉冲持续时间和较少的脉络膜穿透被认为可减轻激光治疗期间的疼痛。

目的

比较接受PASCAL激光或传统激光进行PRP的糖尿病性视网膜病变(PDR)患者所表达的疼痛评分的严重程度。

方法

共有28例诊断为PDR且计划接受双侧PRP治疗的患者纳入前瞻性研究。双眼在同一次治疗中进行治疗,一只眼随机接受PASCAL激光治疗,另一只眼接受传统激光治疗。传统激光的脉冲持续时间调整为100毫秒,PASCAL激光为30毫秒。使用语言量表和视觉模拟量表(VAS)对疼痛严重程度进行分级。

结果

平均年龄为61.36±9.10岁。PASCAL激光组的平均语言评分和VAS评分分别为1.32±0.47和2.86±1.21,传统激光组分别为2.39±0.49和5.75±1.35。两种量表所获得的疼痛评分之间的差异具有统计学意义(p<0.001)。

结论

PASCAL激光可能由于较短的激光脉冲持续时间和较低的强度而显著减轻疼痛程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e779/6354857/988d9019839c/AFHS1804-1010Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e779/6354857/b1b58b11f24c/AFHS1804-1010Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e779/6354857/00276914d511/AFHS1804-1010Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e779/6354857/988d9019839c/AFHS1804-1010Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e779/6354857/b1b58b11f24c/AFHS1804-1010Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e779/6354857/00276914d511/AFHS1804-1010Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e779/6354857/988d9019839c/AFHS1804-1010Fig3.jpg

相似文献

1
PASCAL laser platform produces less pain responses compared to conventional laser system during the panretinal photocoagulation: a randomized clinical trial.在全视网膜光凝术中,与传统激光系统相比,帕斯卡激光平台产生的疼痛反应更少:一项随机临床试验。
Afr Health Sci. 2018 Dec;18(4):1010-1017. doi: 10.4314/ahs.v18i4.22.
2
Comparison of pain scores between patients undergoing panretinal photocoagulation using navigated or pattern scan laser systems.使用导航或模式扫描激光系统进行全视网膜光凝的患者之间疼痛评分的比较。
Arq Bras Oftalmol. 2016 Feb;79(1):15-8. doi: 10.5935/0004-2749.20160006.
3
Comparison of conventional pattern and novel navigated panretinal photocoagulation in proliferative diabetic retinopathy.常规模式与新型导航全视网膜光凝治疗增生性糖尿病视网膜病变的比较。
Invest Ophthalmol Vis Sci. 2014 May 1;55(6):3432-8. doi: 10.1167/iovs.14-13936.
4
Pain responses of Pascal 20 ms multi-spot and 100 ms single-spot panretinal photocoagulation: Manchester Pascal Study, MAPASS report 2.帕斯卡 20 毫秒多靶点和 100 毫秒单靶点全视网膜光凝的疼痛反应:曼彻斯特帕斯卡研究,MAPASS 报告 2。
Br J Ophthalmol. 2010 Nov;94(11):1493-8. doi: 10.1136/bjo.2009.176677. Epub 2010 Jun 16.
5
Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study.增殖性糖尿病视网膜病变中单次与多次模式扫描激光视网膜光凝术:曼彻斯特帕斯卡研究
Arch Ophthalmol. 2010 May;128(5):525-33. doi: 10.1001/archophthalmol.2010.60.
6
Single session of pattern scanning laser versus multiple sessions of conventional laser for panretinal photocoagulation in diabetic retinopathy: Efficacy, safety and painfulness.单眼次模式扫描激光与多次传统激光用于糖尿病视网膜病变全视网膜光凝的疗效、安全性和疼痛性比较。
PLoS One. 2019 Jul 16;14(7):e0219282. doi: 10.1371/journal.pone.0219282. eCollection 2019.
7
Comparison of navigated laser and conventional single-spot laser system for induced pain during panretinal photocoagulation.导航激光与传统单点激光系统在全视网膜光凝术中诱发疼痛的比较。
Lasers Med Sci. 2020 Apr;35(3):687-693. doi: 10.1007/s10103-019-02886-2. Epub 2019 Nov 18.
8
Electroretinogram evaluation for the treatment of proliferative diabetic retinopathy by short-pulse pattern scanning laser panretinal photocoagulation.短脉冲模式扫描激光全视网膜光凝治疗增殖性糖尿病视网膜病变的视网膜电图评估
Lasers Med Sci. 2018 Jul;33(5):1095-1102. doi: 10.1007/s10103-018-2474-0. Epub 2018 Mar 15.
9
Safety and efficacy of panretinal photocoagulation in patients with high-risk proliferative diabetic retinopathy using pattern scan laser versus conventional YAG laser.使用模式扫描激光与传统YAG激光对高危增殖性糖尿病视网膜病变患者进行全视网膜光凝的安全性和有效性。
Kaohsiung J Med Sci. 2016 Jan;32(1):22-6. doi: 10.1016/j.kjms.2015.12.002. Epub 2016 Jan 9.
10
Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study.糖尿病视网膜病变中帕斯卡靶向视网膜与可变强度 20ms 全视网膜 PAN 激光的前瞻性随机临床试验:PETER PAN 研究。
Br J Ophthalmol. 2013 Feb;97(2):220-7. doi: 10.1136/bjophthalmol-2012-302189. Epub 2012 Nov 24.

引用本文的文献

1
Persistent Diabetic Macular Edema: A Comprehensive Review of Current Treatments and Emerging Therapeutic Options.持续性糖尿病黄斑水肿:当前治疗方法及新兴治疗选择的全面综述
J Curr Ophthalmol. 2025 Jun 5;36(3):229-241. doi: 10.4103/joco.joco_133_24. eCollection 2024 Jul-Sep.
2
Recent advances in the treatment and delivery system of diabetic retinopathy.糖尿病视网膜病变的治疗和递药系统的最新进展。
Front Endocrinol (Lausanne). 2024 Feb 15;15:1347864. doi: 10.3389/fendo.2024.1347864. eCollection 2024.
3
Patients' Preference Regarding Laser Photocoagulation or Cryoretinopexy for the Treatment of Retinal Pathology.

本文引用的文献

1
Sex, eyes, and vision: male/female distinctions in ophthalmic disorders.性别、眼睛与视力:眼科疾病中的男女差异
Curr Eye Res. 2015 Feb;40(2):96-101. doi: 10.3109/02713683.2014.975368. Epub 2014 Oct 20.
2
Effects of sex and age on the normal retinal and choroidal structures on optical coherence tomography.性别和年龄对光学相干断层扫描下正常视网膜和脉络膜结构的影响。
Curr Eye Res. 2015 Feb;40(2):213-25. doi: 10.3109/02713683.2014.952828. Epub 2014 Aug 25.
3
Pain score of patients undergoing single spot, short pulse laser versus conventional laser for diabetic retinopathy.
患者对于激光光凝术或冷冻视网膜固定术治疗视网膜病变的偏好
J Vitreoretin Dis. 2021 Jun 2;6(1):47-53. doi: 10.1177/24741264211013649. eCollection 2022 Jan-Feb.
4
Current and Novel Therapeutic Approaches for Treatment of Diabetic Macular Edema.治疗糖尿病性黄斑水肿的当前和新型治疗方法。
Cells. 2022 Jun 17;11(12):1950. doi: 10.3390/cells11121950.
5
Comparison of Pain Scores Among Patients Undergoing Conventional and Novel Panretinal Photocoagulation for Diabetic Retinopathy: A Systematic Review.糖尿病视网膜病变患者接受传统和新型全视网膜光凝治疗的疼痛评分比较:一项系统评价
Clin Ophthalmol. 2021 Mar 2;15:953-971. doi: 10.2147/OPTH.S294227. eCollection 2021.
6
Interface of non-communicable diseases and infections in Africa.非洲非传染性疾病与感染的交叉领域
Afr Health Sci. 2018 Dec;18(4):i-iv. doi: 10.4314/ahs.v18i4.1.
接受单点、短脉冲激光治疗与传统激光治疗的糖尿病视网膜病变患者的疼痛评分。
Graefes Arch Clin Exp Ophthalmol. 2013 Apr;251(4):1103-7. doi: 10.1007/s00417-012-2167-5. Epub 2012 Oct 11.
4
Change in diabetic panretinal photocoagulation incidence.糖尿病性全视网膜光凝发生率的变化。
Ophthalmic Surg Lasers Imaging. 2012 Jul 1;43(4):270-4. doi: 10.3928/15428877-20120618-02.
5
Reduction of fluence to decrease pain during panretinal photocoagulation in diabetic patients.降低能量密度以减轻糖尿病患者全视网膜光凝术中的疼痛。
Ophthalmic Surg Lasers Imaging. 2010 Jul-Aug;41(4):432-6. doi: 10.3928/15428877-20100525-02. Epub 2010 May 28.
6
Pain responses of Pascal 20 ms multi-spot and 100 ms single-spot panretinal photocoagulation: Manchester Pascal Study, MAPASS report 2.帕斯卡 20 毫秒多靶点和 100 毫秒单靶点全视网膜光凝的疼痛反应:曼彻斯特帕斯卡研究,MAPASS 报告 2。
Br J Ophthalmol. 2010 Nov;94(11):1493-8. doi: 10.1136/bjo.2009.176677. Epub 2010 Jun 16.
7
Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser.比较 532nm 标准激光与多点模式扫描激光治疗糖尿病视网膜病变的疗效。
Retina. 2010 Mar;30(3):452-8. doi: 10.1097/IAE.0b013e3181c70127.
8
Oral versus topical diclofenac for pain prevention during panretinal photocoagulation.口服与局部应用双氯芬酸预防全视网膜光凝术中疼痛的比较。
Ophthalmology. 2009 Jun;116(6):1168-74. doi: 10.1016/j.ophtha.2009.01.022. Epub 2009 Apr 19.
9
Effect of pulse duration on size and character of the lesion in retinal photocoagulation.脉冲持续时间对视网膜光凝术中病变大小及特征的影响。
Arch Ophthalmol. 2008 Jan;126(1):78-85. doi: 10.1001/archophthalmol.2007.29.
10
Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times.接受缩短曝光时间的全视网膜激光光凝治疗患者的疼痛反应及随访
Eye (Lond). 2008 Jan;22(1):96-9. doi: 10.1038/sj.eye.6703026. Epub 2007 Nov 23.